Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Invested Capital: 2013-2025

Historic Invested Capital for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $65.2 million.

  • Fortress Biotech's Invested Capital rose 611.74% to $65.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.2 million, marking a year-over-year increase of 611.74%. This contributed to the annual value of $22.7 million for FY2024, which is 0.86% up from last year.
  • Per Fortress Biotech's latest filing, its Invested Capital stood at $65.2 million for Q3 2025, which was up 48.40% from $43.9 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Invested Capital peaked at $248.3 million during Q2 2021, and registered a low of -$15.9 million during Q2 2023.
  • For the 3-year period, Fortress Biotech's Invested Capital averaged around $13.3 million, with its median value being $19.8 million (2023).
  • In the last 5 years, Fortress Biotech's Invested Capital tumbled by 119.88% in 2024 and then surged by 925.15% in 2025.
  • Fortress Biotech's Invested Capital (Quarterly) stood at $225.9 million in 2021, then slumped by 77.85% to $50.0 million in 2022, then plummeted by 54.93% to $22.5 million in 2023, then rose by 0.86% to $22.7 million in 2024, then surged by 611.74% to $65.2 million in 2025.
  • Its Invested Capital stands at $65.2 million for Q3 2025, versus $43.9 million for Q2 2025 and $32.5 million for Q1 2025.